Revised: 18 December 2023
Information for Consumers
Information that everyone should know about medicines and medical devices including updates on staying safe and healthy.
Things you should know
| Date | Type | Title |
|---|---|---|
| 20/2/2026 | Consultation | Verification Pathway for New Medicine Applications |
| 16/2/2026 | Medicines | Policy Statements - Declaring excipient(s) with known effect in data sheets |
| 26/1/2026 | Monitoring Communication |  Glucagon-like peptide-1 receptor agonists (dulaglutide, liraglutide, semaglutide, tirzepatide) and acute persistent visual loss |
| 15/1/2026 | Notices | Updated Clinical Trial Guidelines |
| 15/1/2026 | Consultation | Outcome of the consultation on the proposed updates to the Guideline on the Regulation of Therapeutic Products in New Zealand: Clinical Trials |
| 15/1/2026 | Consultation | Proposed extension of the abbreviated procedure for new medicine applications and section 24(5)(a) notifications |
| 7/1/2026 | Notices | Notice of Medsafe Office Closure Christmas/New Year 2025/2026 |
If you have a question that is not answered by the information on these pages please contact us at
askmedsafe@health.govt.nz
You can also subscribe to receive a list of changes to Medsafe's website by email
